Skip to main content

Table 1 Clinical and hematological features of MDS patients

From: Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors

N° of patients

54

Sex (male/female)

34/20

Age, median years (range)

69 (15–84)

WHO classification, n° (%) of the patients

 

RA

7 (13)

RCMD

24 (45)

RCMD-RS

11 (20)

RAEB-1

6 (11)

RAEB-2

6 (11)

IPSS-R risk group of the patients

 

Very Low

5

Low

17

Intermediate

16

High

10

Very High

3

IPSS risk group of the patients

 

Low

15

Intermediate-1

25

Intermediate-2

9

High

2

WPSS of the patients

 

Very low

3

Low

12

Intermediate

22

High

12

Very High

2

  1. WHO, World Health Organization; RA, refractory anemia; RCMD, refractory cytopenia with multilineage dysplasia; RAEB, refractory anemia with excess blasts; IPSS International Prognostic Scoring System; WPSS, WHO classification- based prognostic scoring system; ANC, absolute neutrophil count.